NCT05935306 Effect of Photobiomodulation to Reduce Post-operative Pain After Endodontic Surgery
| NCT ID | NCT05935306 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nove de Julho |
| Condition | Photobiomodulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2024-06-30 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2024-06-30 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study will be to evaluate if photobiomodulation (FBM) can reduce postoperative pain in patients who will undergo endodontic surgery. For this randomized, controlled and double-blind clinical study, 34 patients without comorbidities who need endodontic surgery in the upper jaw (15 to 25 teeth) will be recruited. They will be randomly divided into an experimental group (n = 17) photobiomodulation (808nm, 100 mW, and 4J/cm2 with 5 points per vestibular). Applications will be made in the immediate postoperative period and 24 hours after surgery. Control group (n = 17) a FBM simulation will be performed in the same way as in the experimental group. In this group, the required analgesia will be administered within the standard with ibuprofen. Both groups will perform the necessary conventional procedures considered the gold standard in the literature. Both the patient and the evaluator will be blinded to the intervention performed. The primary outcome variable of the study will be postoperative pain, which will be assessed using the visual analog scale at all postoperative control visits (baseline, 24 hours and 7 days). As for the secondary outcome variables, the amount of systemic medication received according to the patient's need (will be provided by the investigator).. Radiographic images will be obtained after 1 and 2 months for evaluation of the repair (dimensions of the lesion, radiopacity). These radiographs will be taken digitally with the positioners implemented. Edema, ecchymosis, and evaluation of soft tissues in the anterior portion of the intra and extra-oral maxilla will also be evaluated. In addition, a digital thermometer. These parameters will be evaluated 24 hours and 7 days after the intervention. The X-rays will be taken in the 1st and 3rd month respectively.
Eligibility Criteria
Inclusion Criteria :• Patients with periapical lesions who have already undergone endodontic treatment (lesions smaller than 10mm in their greatest diameter - Metin et al., 2018, single and chronic lesions) * Patients with not comorbidities, * Age from 18 to 70 years, * Both genders, * Healthy permanent teeth with good hygiene. Exclusion Criteria: * Who are taking drugs that affect bone metabolism and the inflammatory process (for example: corticosteroids, bisphosphonates), * Smokers, pregnant or lactating women, * Who used anti-inflammatory drugs in the last 3 months before surgery. * Who for any reason interrupted the evolution of the treatment for not attending joint appointments. * Patients who do not follow the guidelines or have an injury in the acute phase (pain, edema, exudate)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05935306 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Photobiomodulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05935306 currently recruiting?
Yes, NCT05935306 is actively recruiting participants. Contact the research team at drconsolandich@gmail.com for enrollment information.
Where is the NCT05935306 trial being conducted?
This trial is being conducted at Montevideo, Uruguay.
Who is sponsoring the NCT05935306 clinical trial?
NCT05935306 is sponsored by University of Nove de Julho. The trial plans to enroll 34 participants.